title: Successful treatment of delayed pressure urticaria with anti-TNF-alpha.
authors.forename: Markus
authors.initials: M
authors.lastname: Magerl
authors.forename: Sandra
authors.initials: S
authors.lastname: Philipp
authors.forename: Maria
authors.initials: M
authors.lastname: Manasterski
authors.forename: Markus
authors.initials: M
authors.lastname: Friedrich
authors.forename: Marcus
authors.initials: M
authors.lastname: Maurer
mesh_terms: D000328:Adult; D000068800:Etanercept; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*; D014581:Urticaria / Q000188:drug therapy*
chemical_list: D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept